Michael Gilman's Net Worth
$6.53 Million
Who is Michael Gilman?
Michael Gilman has an estimated net worth of $6.53 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC, Scholar Rock Holding Corp, and EPIX Pharmaceuticals, Inc..
SEC CIK
Michael Gilman's CIK is 0001291144
Past Insider Trading and Trends
2004 was Michael Gilman's most active year for acquiring shares with 7 total transactions. Michael Gilman's most active month to acquire stocks was the month of May. 2004 was Michael Gilman's most active year for disposing of shares, totalling 11 transactions. Michael Gilman's most active month to dispose stocks was the month of November. 2004 saw Michael Gilman paying a total of $2,534,149.35 for 87,013 shares, this is the most they've acquired in one year. In 2004 Michael Gilman cashed out on 116,026 shares for a total of $3,727,722.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC (BIIB) Snapshot price: $200.5
EVP - Research
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
$56.25 | -$287,452.70 | 23K |
Scheduled
|
Dec 28
| ||
Form 4
|
—
|
0
|
$53.00 | -$367,320.65 | 22.52K |
Scheduled
|
Dec 9
| ||
Form 4
|
—
|
0
|
$53.52 | -$538,800.00 | 14.5K |
Scheduled
|
Sep 13
| ||
Form 4
| +44.61% | 4K |
—
|
—
| 12.97K |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Scholar Rock Holding Corp (SRRK) Snapshot price: $8.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 13.5K |
—
|
—
| 13.5K |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
| 37.46K |
Jul 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
| -11.14% | -4.70K |
$65.59 | -$307,998.43 | 37.46K |
Scheduled
|
Mar 15
| ||
Form 4
| -4.10% | -1.80K |
$65.06 | -$117,360.66 | 42.16K |
Scheduled
|
Feb 8
| ||
Form 4
|
—
|
0
|
$32.52 | -$187,268.34 | 43.96K |
Scheduled
|
Jan 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EPIX Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||